RVAC Medicines Pte. Ltd. ("RVAC"), an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group ("CBC"), announced the completion of its...
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) announced a planned development partnership with a private developer, the State of Kansas,...
Pharming Group N.V. announces that it has received a positive decision from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) on a Paediatric...
Protagonist Therapeutics announced topline results from the Phase 2 IDEAL study evaluating PN-943 in patients with moderate-to-severe ulcerative colitis (UC).
Also Read: Glass Lewis Proxy...
